Dockets Entered On 05/27/2003
Docket # Title
2000N-1571 Enrofloxacin for Poultry:
Opportunity for Hearing
2003P-0217 Concept:Shared exclusivity- ANDAs submitted same day
2003P-0218 ANDA:Glipizide and Metformin HCI Tablets for Oral Solution
2003P-0219 ANADA Suitability for Amoxicillin Oral Paste
CS
41 HFA-305 Vol #: 368
CS
42 HFA-305 Vol #: 368
EXB
1 Bayer Corporation Vol #: 377
EXB
2 Bayer Corporation Vol #: 377
EXB
3 Bayer Corporation Vol #: 377
EXB
4 Bayer Corporation Vol #: 377
EXB 5 Bayer Corporation Vol #: 377
EXB
6 Bayer Corporation Vol #: 377
EXB
7 Center for Veterinary Medicine Vol #: 377
EXB
8 Center for Veterinary Medicine Vol #: 377
MO
47 Bayer Corporation Vol #: 368
MO
48 Bayer Corporation & AHI Vol #: 368
MO
49 Animal Health Institute Vol #: 368
OR
43 HF-3 Vol #: 368
OR
44 HF-3 Vol #: 368
SF
2 GCF-1 Vol #: 368
TR
6 Transcript from May 5, 2003 Vol #: 374
TR
7 Transcript from May 6, 2003 Vol #: 375
TR
8 Transcript from May 7, 2003 Vol #: 376
2002N-0204 Bar Code Label Requirements
for human drug products
EC 55 Wallace, James Vol #: 17
EC 56 Pederson, Larry Vol #: 17
2003N-0069 FDA Task Force on Consumer Health
Info for Better Nutrition
EC 62 Perszewski, Gail Vol #: 2
CP
1 Ranbaxy Laboratories Limited Vol #: 1
ACK 1 HFA-305 to Weinberg Group Inc. Vol
#: 1
CP
1 The Weinberg Group Inc. Vol #: 1
ACK 1 HFA-305 to Vetoquinol N.-A. Inc.
Vol #: 1
CP
1 Vetoquinol N.-A. Inc. Vol #: 1
|
